Evaluating the likelihood of pediatric sacral nerve stimulator explantations due to cure or complications: a survival analysis of 13-year institutional cohort - Takeaways - MDSpire

Evaluating the likelihood of pediatric sacral nerve stimulator explantations due to cure or complications: a survival analysis of 13-year institutional cohort

  • By

  • Jin Kyu Kim

  • Konrad M. Szymanski

  • Rosalia Misseri

  • Shelly J. King

  • Nikhil V. Batra

  • Martin Kaefer

  • Mark P. Cain

  • Richard C. Rink

  • Joshua Roth

  • Pankaj Dangle

  • Kirstan Meldrum

  • Benjamin M. Whittam

  • August 28, 2025

  • 0 min

Share

  • 1

    Pediatric bladder bowel dysfunction (BBD) can lead to significant health issues, necessitating effective management strategies for symptom relief.

  • 2

    Sacral nerve modulation (SNM) has shown promising results in treating refractory BBD in children, with 70-80% experiencing significant improvement.

  • 3

    In a cohort study, 36.4% of pediatric patients underwent SNM explantation, primarily due to symptom resolution (72.3%) rather than complications.

  • 4

    The median time to SNM explantation was 6.0 years, with a higher likelihood of explantation for cure compared to complications.

  • 5

    Post-explantation follow-up indicated that 94.4% of patients who achieved cure maintained symptom resolution without medication.

Original Source(s)

Related Content